Daniel Homerick

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Christine Beeton, Heike Wulff, Nathan Standifer et al. · Proceedings of the National Academy of Sciences · 2006 · 538 citations

Life Sciences, Cell Biology, Immunology +17

Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam et al. · Molecular Pharmacology · 2005 · 224 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis

Philippe Azam, Ananthakrishnan Sankaranarayanan, Daniel Homerick et al. · Journal of Investigative Dermatology · 2007 · 95 citations · Full text

Life Sciences, Dermatology, Immunology +12

Pharmacological Profiling of Orthochirus scrobiculosus Toxin 1 Analogs with a Trimmed N-Terminal Domain

Stéphanie Mouhat, Georgeta Teodorescu, Daniel Homerick et al. · Molecular Pharmacology · 2005 · 38 citations

Medicine, Medicinal Chemistry, Pharmacology +15

A New Class of Blockers of the Voltage-Gated Potassium Channel Kv1.3 via Modification of the 4- or 7-Position of Khellinone

Andrew J. Harvey, Jonathan B. Baell, Nathan Toovey et al. · Journal of Medicinal Chemistry · 2006 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14